You are required to be logged in to access the full website
User Name: Password:
Click here if you have forgotten your username or password
  • Home
  • Latest News
  • Search
  • About M2 Pharma
  • Subscribe
Business & Finance
Generics
Therapy Areas
Policy & Regulation
Research & Development
People
Policy & Regulation
Calidi Biotherapeutics Names Heehyoung Lee to Board of Directors
Login
Username:

Password:


Related Headlines

BioArctic and Eisai report positive five-year data for Leqembi in early Alzheimer's disease

Akeso submits sNDA for ivonescimab chemotherapy combination in first-line biliary tract cancer

AstraZeneca rare disease unit secures US and EU approvals for Klygefa in myasthenia gravis

Genentech secures first FDA approval for primary membranous nephropathy treatment

TRIMTECH Therapeutics partners with Biogen to develop protein degraders for neurodegenerative diseases

Aelis Farma announces receipt of second positive safety recommendation for Down syndrome trial

CARsgen's satri-cel CAR-T product included in China's Commercial Health Insurance Innovative Drug List

Specialised Therapeutics' YONDELIS sarcoma therapy approved in Thailand

Rezolute's ersodetug meets primary endpoint in Phase 3 upLIFT study of tumour hyperinsulinism

Eisai launches subcutaneous Leqembi Pen in Japan for early Alzheimer's disease

Breakthrough T1D and Walgreens Foundation join forces to support the type 1 diabetes community

Innovent Biologics presents preclinical data for IL-6/TL1A bispecific antibody IAR177

FDA grants Breakthrough Therapy designation to Clarity Pharmaceuticals' prostate cancer imaging agent

Traws Pharma reports final Phase 2a COVID-19 data and advances influenza programme

Shanton Pharma's SAP-001 receives EMA and FDA paediatric study waivers in hyperuricaemia

Home | Business & Finance | Generics | Therapy Areas | Policy & Regulation | Research & Development | People | Search | About M2 Pharma | Subscribe
Copyright © 2026